A Modern Disease of an Unnatural Ratio
Throughout nearly all of human evolution, dietary omega-6 and omega-3 fatty acids were consumed in near parity. Wild plants, nuts, and wild game provided roughly balanced levels of alpha‑linolenic acid (ALA, ω‑3) and linoleic acid (LA, ω‑6). Industrialization introduced two radical changes: mass production of seed oils such as corn, soybean, safflower, and sunflower—each extremely rich in ω‑6 LA—and the conversion of livestock feed from grass to grain (Simopoulos, 2002). These shifts transformed animal‑source foods, moving their fatty acid composition from an ancestral ω‑6:ω‑3 ratio near 2:1–4:1 to modern ratios exceeding 20:1 (Daley et al., 2010). No human population before the 20th century ever experienced such disproportion. This distortion is entirely an artifact of industrial agriculture and food processing, yet it has rewritten the molecular language of the human brain.
Abstract: Epilepsy has long been understood as a disorder of abnormal neuronal firing, yet a growing body of evidence reveals a deeper biochemical foundation rooted in lipid composition and endocannabinoid signaling. The human brain—composed largely of polyunsaturated fatty acids (PUFAs)—depends on a precise omega‑6 to omega‑3 ratio to maintain excitatory‑inhibitory balance, synaptic plasticity, and endocannabinoid tone. Modern dietary patterns, dominated by industrial seed oils and grain‑fed livestock, have distorted this ratio from its ancestral equilibrium (~1:1) to levels exceeding 20:1 or higher (Simopoulos, 2016). This imbalance alters membrane fluidity, biases immune signaling toward arachidonic‑acid‑derived pro‑inflammatory pathways, and causes endocannabinoid receptor fatigue through chronic CB1 overstimulation. The result is impaired neuroinhibition, oxidative stress, and hyperexcitability—hallmarks of epileptic terrain.
1. A Modern Disease of an Unnatural Ratio
Throughout nearly all of human evolution, dietary omega‑6 and omega‑3 fatty acids were consumed in near parity. Industrialization introduced mass production of seed oils rich in ω‑6 LA and conversion of livestock feed from grass to grain (Simopoulos, 2002). These shifts transformed animal‑source foods from an ancestral ω‑6:ω‑3 ratio near 2:1–4:1 to modern ratios exceeding 20:1 (Daley et al., 2010). No human population before the 20th century ever experienced such disproportion.
2. The Brain: A Lipid Organ of Extraordinary Sensitivity
Approximately 60% of the dry weight of the human brain is lipid, and nearly one‑third of this fraction consists of PUFAs – predominantly arachidonic acid (AA, ω‑6) and docosahexaenoic acid (DHA, ω‑3) (Salem et al., 2001). These fatty acids dictate membrane fluidity, receptor conformation, ion channel kinetics, and synaptic vesicle fusion. DHA is particularly concentrated in neuronal membranes, supporting rapid electrical signaling and resilience to oxidative stress (Lauritzen et al., 2016). When omega‑6 predominates, membranes become more rigid, oxidation‑prone, and biased toward excitatory signaling. The ω‑6:ω‑3 ratio therefore functions as a molecular rheostat for neural communication and plasticity.
3. Cellular Consequences of Omega‑6 Overload
Cells enriched with omega‑6‑derived lipids exhibit profound functional alterations. Excess arachidonic acid activates phospholipase A₂, increasing liberation of inflammatory eicosanoids – prostaglandins, thromboxanes, and leukotrienes (Calder, 2010). Chronic turnover of AA produces excessive 2‑arachidonoylglycerol (2‑AG), an endocannabinoid that, although initially inhibitory, overstimulates CB1 receptors when persistently elevated (Di Marzo, 2018). Receptor desensitization and internalization follow, weakening inhibitory control over glutamate release. Simultaneously, omega‑6‑rich membranes undergo lipid peroxidation, generating reactive aldehydes such as 4‑hydroxynonenal (4‑HNE) that adduct proteins and DNA, degrading mitochondrial and receptor integrity (Ayala et al., 2014). The cumulative result is diminished CB1 responsiveness, chronic inflammation, and neuronal hyperexcitability – a biochemical environment primed for epileptogenesis.
4. The Endocannabinoid System: Homeostatic Regulator of Excitability
The ECS serves as the brain's master feedback network, modulating neurotransmission, inflammation, and metabolism (Zou & Kumar, 2018). CB1 receptors, densely expressed on presynaptic terminals, inhibit neurotransmitter release – especially glutamate and GABA – thereby fine‑tuning excitatory‑inhibitory balance. When dietary ω‑6 intake dominates, 2‑AG synthesis rises disproportionately, while anandamide (AEA) and ω‑3‑derived congeners (e.g., DHEA, EPEA) decline (Watkins & Kim, 2015). This biochemical skew results in chronic CB1 activation followed by desensitization. Once CB1 tone is lost, presynaptic neurons release unchecked glutamate, and astrocytic calcium signaling amplifies local excitation (Katona & Freund, 2012). In essence, an omega‑6‑loaded ECS becomes incapable of braking neuronal circuits, predisposing the cortex and hippocampus to seizure‑like discharges.
Key insight: The ω‑6:ω‑3 ratio sets the background tone for endocannabinoid synthesis; endocannabinoid tone dictates CB1 receptor expression; and receptor expression determines the brain’s ability to regulate excitation.
5. The Role of Special Pro‑Resolving Mediators (SPMs)
Omega‑3 fatty acids—EPA and DHA—are precursors to specialized pro‑resolving mediators (SPMs) such as resolvins, protectins, and maresins. These compounds actively terminate inflammation and restore tissue homeostasis without suppressing immune competence (Serhan & Levy, 2018). In epilepsy, where neuronal injury begets neuroinflammation, the absence of SPMs means the inflammatory response never fully resolves. Microglia remain activated, cytokines persist, and excitatory circuits stay primed for recurrent seizures.
6. Oxidative Stress: The Final Common Pathway
Omega‑6 PUFAs, with multiple double bonds, are highly susceptible to peroxidation. Their oxidation yields reactive aldehydes and hydroperoxides that damage mitochondria, modify CB1 receptors, and disrupt intracellular calcium homeostasis (Ghosh et al., 2016). Lipid peroxidation thus represents both a cause and a consequence of seizure activity. DHA, by contrast, resists peroxidation and fosters production of neuroprotective mediators such as neuroprotectin D1, which suppresses excitotoxicity (Bazan, 2011). The predominance of easily oxidized omega‑6 fats therefore locks the nervous system into a self‑reinforcing loop of oxidative stress, receptor dysfunction, and electrical instability.
7. Reframing Epilepsy: A Nutritional and Bioelectrical Disorder
Viewed through the lens of lipid biochemistry and the ECS, epilepsy emerges not merely as an electrical storm but as a metabolic communication failure. The ω‑6:ω‑3 ratio sets the background tone for endocannabinoid synthesis; endocannabinoid tone dictates CB1 receptor expression; and receptor expression determines the brain's ability to regulate excitation. Concurrent deficiency in SPMs and antioxidant defenses ensures that inflammation and oxidative stress persist. Correcting these inputs—by reducing omega‑6 seed oils, increasing marine or algal omega‑3s, supporting antioxidant status, and modulating the ECS with non‑intoxicating cannabinoids such as CBD—rebuilds the biochemical terrain necessary for stable neuronal firing (Devinsky et al., 2018).
8. Conclusion
Epilepsy, at its biochemical core, represents a failure of endocannabinoid‑mediated homeostasis within an unnatural lipid environment. The modern diet's distortion of the omega‑6 to omega‑3 ratio has altered neuronal membrane composition, compromised CB1 receptor function, and blocked the natural resolution chemistry provided by SPMs. The resulting terrain is oxidized, excitatory, and unstable—conditions ideally suited for seizure propagation. Restoring omega‑3 sufficiency, supporting ECS balance, and reducing oxidative stress represent rational strategies for terrain correction and neurological recovery. Far from being a purely electrical disorder, epilepsy reflects a deeper ecological mismatch between human biology and the industrial diet that fuels it.
Selected references: Ayala et al., 2014; Bazinet & Layé, 2014; Bazan, 2011; Calder, 2010, 2017; Daley et al., 2010; Devinsky et al., 2018; Di Marzo, 2018; Ghosh et al., 2016; Katona & Freund, 2012; Lauritzen et al., 2016; Salem et al., 2001; Serhan & Levy, 2018; Simopoulos, 2002, 2016; Watkins & Kim, 2015; Zou & Kumar, 2018.
